The DOI matches its Crossref record; 204 of the 204 references it cites were found in a registry or an index.
An excitatory synapse hypothesis of depression
Open accessAbstract
Depression is a common cause of mortality and morbidity, but the biological bases of the deficits in emotional and cognitive processing remain incompletely understood. Current antidepressant therapies are effective in only some patients and act slowly. Here, we propose an excitatory synapse hypothesis of depression in which chronic stress and genetic susceptibility cause changes in the strength of subsets of glutamatergic synapses at multiple locations, including the prefrontal cortex (PFC), hippocampus, and nucleus accumbens (NAc), leading to a dysfunction of corticomesolimbic reward circuitry that underlies many of the symptoms of depression. This hypothesis accounts for current depression treatments and suggests an updated framework for the development of better therapeutic compounds.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It appears that increased strength of excitatory neurotransmission, in particular involving AMPARs, represents a common downstream target that is necessary for antidepressant efficacy among classical and rapid-acting antidepressants (Alt et al., 2006; Gould et al., 2019; Thompson et al., 2015).”
From Mechanisms of ketamine and its metabolites as antidepressants (2022) · cites this paper as Thompson et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Collectively, these patterns observed in human patients are consistent with the premise that neuronal and molecular plasticity deficits may feed forward to impairments in the coordinated function of prefrontal and limbic regions 66 , resulting in impaired PFC regulation and unchecked stimulus-driven responses to salient negative stimuli.”
From Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model (2020) · cites this paper as [66]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although stress-induced structural changes in the PFC are equally important in their contribution to the pathophysiology of neuropsychiatric conditions [256–262]”
From Development of prefrontal cortex (2022) · cites this paper as [259]
Experimental — accuracy not yet measuredIn the citing paper
“Conventional antidepressant therapeutics including selective serotonin reuptake inhibitors (SSRIs) or non-typical therapeutics, including ketamine and brain stimulation, may alleviate depression symptoms by acting on excitatory brain systems (33).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [33]
In the citing paper
“Stress-induced dysfunction in forebrain excitatory transmission has led to the development of the excitatory synaptic transmission hypothesis of depression (22, 32, 33).”
From Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression (2017) · cites this paper as [33]
In the citing paper
“As glutamate clearance modulates neuronal excitability [200] and glutamatergic synapse strength contributes to depression [202], how astrocytic glutamate clearance contributes to excitatory synapse strength and subsequent depressive behavior is also worth further investigation in the reward circuit.”
From The molecular and cellular mechanisms of depression: a focus on reward circuitry (2019) · cites this paper as [202]
In the citing paper
“Indeed, a net result of all these processes is a sustained potentiation of excitatory synapses in cortico-mesolimbic brain circuits involved in the maintenance of mood and stress-reactivity 190.”
From Mechanisms of ketamine action as an antidepressant (2018) · cites this paper as [190]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene
Caspi, A., Sugden, K., Moffitt, T. E., Taylor, A., Craig, I. W., Harrington, H., McClay, J., Mill, J., Martin, J., Braithwaite, A., et al. (2003) · Science · doi:10.1126/science.1083968 · Cited by 8,120
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The Neuroendocrinology of Stress: A Never Ending Story
Lightman, S. L. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01711.x · Cited by 3,588
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
Schildkraut, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,568
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375
Nestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Cited by
Sorted by citations
Mechanisms of ketamine action as an antidepressant
Zanos, P., & Gould, T. D. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.255 · Cited by 1,127
The Inositol Trisphosphate/Calcium Signaling Pathway in Health and Disease
Berridge, M. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00006.2016 · Cited by 779
Neuroplasticity in cognitive and psychological mechanisms of depression: an integrative model
Price, R. B., & Duman, R. (2020) · Molecular Psychiatry · doi:10.1038/s41380-019-0615-x · Cited by 739
Howard, D. M., Adams, M. J., Shirali, M., Clarke, T.-K., Marioni, R. E., Davies, G., Coleman, J. R. I., Alloza, C., Shen, X., Barbu, M. C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03819-3 · Cited by 612
Dendritic Spines in Depression: What We Learned from Animal Models
Qiao, H., Li, M.-X., Xu, C. S., Chen, H.-B., An, S.-C., & Ma, X. (2016) · Neural Plasticity · doi:10.1155/2016/8056370 · Cited by 463
Development of prefrontal cortex
Kolk, S. M., & Rakic, P. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-021-01137-9 · Cited by 378
Hesselgrave, N., Troppoli, T. A., Wulff, A. B., Cole, A. B., & Thompson, S. M. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2022489118 · Cited by 378
Self-citationHare, B. D., & Duman, R. S. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0685-9 · Cited by 366
Fee, C., Banasr, M., & Sibille, E. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.05.024 · Cited by 329
Reward behaviour is regulated by the strength of hippocampus–nucleus accumbens synapses
LeGates, T. A., Kvarta, M. D., Tooley, J. R., Francis, T. C., Lobo, M. K., Creed, M. C., & Thompson, S. M. (2018) · Nature · doi:10.1038/s41586-018-0740-8 · Cited by 290
Self-citationKetamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Nugent, A. C., Ballard, E. D., Gould, T. D., Park, L. T., Moaddel, R., Brutsche, N. E., & Zarate, C. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0028-2 · Cited by 250
Dendritic spines: Revisiting the physiological role
Chidambaram, S. B., Rathipriya, A. G., Bolla, S. R., Bhat, A., Ray, B., Mahalakshmi, A. M., Manivasagam, T., Thenmozhi, A. J., Essa, M. M., Guillemin, G. J., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.01.005 · Cited by 266
Sex differences in antidepressant efficacy
LeGates, T. A., Kvarta, M. D., & Thompson, S. M. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0156-z · Cited by 242
Self-citationThe molecular and cellular mechanisms of depression: a focus on reward circuitry
Fox, M. E., & Lobo, M. K. (2019) · Molecular Psychiatry · doi:10.1038/s41380-019-0415-3 · Cited by 232
Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression
Francis, T. C., & Lobo, M. K. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.09.007 · Cited by 230
Page, C. E., & Coutellier, L. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.07.024 · Cited by 213
Shu, X., Sun, Y., Sun, X., Zhou, Y., Bian, Y., Shu, Z., Ding, J., Lu, M., & Hu, G. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1813-9 · Cited by 203
Fuchs, T., Jefferson, S. J., Hooper, A., Yee, P.-H., Maguire, J., & Luscher, B. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.188 · Cited by 204
Gui, W.-S., Xiao, W., Mai, C.-L., Murugan, M., Wu, L., Xin, W., Zhou, L., & Liu, X. (2016) · Molecular Pain · doi:10.1177/1744806916646784 · Cited by 198
Cerniauskas, I., Winterer, J., de Jong, J. W., Lukacsovich, D., Yang, H., Khan, F., Peck, J. R., Obayashi, S. K., Lilascharoen, V., Lim, B. K., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.09.005 · Cited by 187
Vitamin D and Depression: Cellular and Regulatory Mechanisms
Berridge, M. J. (2017) · Pharmacological Reviews · doi:10.1124/pr.116.013227 · Cited by 194
Convergent Mechanisms Underlying Rapid Antidepressant Action
Zanos, P., Thompson, S. M., Duman, R. S., Zarate, C. A., & Gould, T. D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0492-x · Cited by 171
Self-citationMechanisms of ketamine and its metabolites as antidepressants
Hess, E. M., Riggs, L. M., Michaelides, M., & Gould, T. D. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114892 · Cited by 175
Ma, K., Xu, A., Cui, S., Sun, M.-R., Xue, Y.-C., & Wang, J.-H. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.181 · Cited by 168
Glutamatergic Neurotransmission: Pathway to Developing Novel Rapid-Acting Antidepressant Treatments
Kadriu, B., Musazzi, L., Henter, I. D., Graves, M., Popoli, M., & Zarate, C. A. (2019) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy094 · Cited by 165
Li, M., Zheng, H.-L., Luo, Y., He, J.-G., Wang, W., Han, J., Zhang, L., Wang, X., Ni, L., Zhou, H.-Y., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.76 · Cited by 163
( 2R,6R )-hydroxynorketamine exerts mGlu 2 receptor-dependent antidepressant actions
Zanos, P., Highland, J. N., Stewart, B. W., Georgiou, P., Jenne, C. E., Lovett, J., Morris, P. J., Thomas, C. J., Moaddel, R., Zarate, C. A., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1819540116 · Cited by 152
Neuronal correlates of depression
Chaudhury, D., Liu, H., & Han, M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2044-6 · Cited by 150
Molecular Pharmacology and Neurobiology of Rapid-Acting Antidepressants
Gould, T. D., Zarate, C. A., & Thompson, S. M. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010617-052811 · Cited by 133
“It is hypothesized that antidepressant-mediated synaptic potentiation occurs selectively in circuits that are abnormally weakened in depression (5, 123) (Figure 3).”
BackgroundInfluentialSelf-citationDas, R. K., Emon, M. P. Z., Shahriar, M., Nahar, Z., Islam, S. M. A., Bhuiyan, M. A., Islam, S. N., & Islam, M. R. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.113568 · Cited by 135
Fischell, J., Van Dyke, A. M., Kvarta, M. D., LeGates, T. A., & Thompson, S. M. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.112 · Cited by 122
Self-citationRen, Z., Pribiag, H., Jefferson, S. J., Shorey, M., Fuchs, T., Stellwagen, D., & Luscher, B. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2016.02.009 · Cited by 114
Yao, N., Skiteva, O., Zhang, X., Svenningsson, P., & Chergui, K. (2018) · Molecular Psychiatry · doi:10.1038/mp.2017.239 · Cited by 118
GABAA receptors as targets for treating affective and cognitive symptoms of depression
Lüscher, B., Maguire, J. L., Rudolph, U., & Sibille, E. L. (2023) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2023.06.009 · Cited by 122
Effects of chronic stress on cognitive function – From neurobiology to intervention
Girotti, M., Bulin, S. E., & Carreno, F. R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100670 · Cited by 170
The Nucleus Accumbens: A Common Target in the Comorbidity of Depression and Addiction
Xu, L., Nan, J., & Lan, Y. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.00037 · Cited by 123
Page, C. E., Shepard, R. M., Heslin, K. A., & Coutellier, L. D. (2019) · Scientific Reports · doi:10.1038/s41598-019-56424-9 · Cited by 111
Praveenraj, S. S., Sonali, S., Anand, N., Hediyal, T. A., Vichitra, C., Kalyan, M., Kanna, P. V., Chandana, K. A., Paneyala, S., Mahalakshmi, A. M., et al. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02990-5 · Cited by 116
Zanos, P., Nelson, M. E., Highland, J. N., Krimmel, S. R., Georgiou, P., Gould, T. D., & Thompson, S. M. (2017) · eNeuro · doi:10.1523/eneuro.0285-16.2017 · Cited by 106
Self-citationA Dendrite-Focused Framework for Understanding the Actions of Ketamine and Psychedelics
Savalia, N. K., Shao, L.-X., & Kwan, A. C. (2021) · Trends in Neurosciences · doi:10.1016/j.tins.2020.11.008 · Cited by 104
Csabai, D., Wiborg, O., & Czéh, B. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00024 · Cited by 102
Negr1 controls adult hippocampal neurogenesis and affective behaviors
Noh, K., Lee, H., Choi, T.-Y., Joo, Y., Kim, S.-J., Kim, H., Kim, J. Y., Jahng, J. W., Lee, S., Choi, S.-Y., et al. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0347-3 · Cited by 86
Thompson, S. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01728-8 · Cited by 101
Self-citationBozzelli, P. L., Alaiyed, S., Kim, E., Villapol, S., & Conant, K. E. (2018) · Neural Plasticity · doi:10.1155/2018/5735789 · Cited by 93
Ketamine and the Future of Rapid-Acting Antidepressants
Riggs, L. M., & Gould, T. D. (2021) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072120-014126 · Cited by 87
Kvarta, M. D., Bradbrook, K. E., Dantrassy, H. M., Bailey, A. M., & Thompson, S. M. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00359.2015 · Cited by 86
Self-citationAlaiyed, S., McCann, M., Mahajan, G., Rajkowska, G., Stockmeier, C. A., Kellar, K. J., Wu, J. Y., & Conant, K. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2387-19.2020 · Cited by 84
Cole, A. B., Montgomery, K. R., Bale, T. L., & Thompson, S. M. (2022) · Neurobiology of Stress · doi:10.1016/j.ynstr.2022.100473 · Cited by 93
Self-citationMolecular, Functional, and Structural Imaging of Major Depressive Disorder
Zhang, K., Zhu, Y., Zhu, Y., Wu, S., Liu, H., Zhang, W., Xu, C., Zhang, H., Hayashi, T., & Tian, M. (2016) · Neuroscience Bulletin · doi:10.1007/s12264-016-0030-0 · Cited by 87
Tan, X., Du, X., Jiang, Y., Botchway, B. O. A., Hu, Z., & Fang, M. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00434 · Cited by 80
Structural neural plasticity evoked by rapid-acting antidepressant interventions
Liao, C., Dua, A. N., Wojtasiewicz, C., Liston, C. M., & Kwan, A. C. (2024) · Nature reviews. Neuroscience · doi:10.1038/s41583-024-00876-0 · Cited by 81
Zhu, Z., Wang, G., Ma, K., Cui, S., & Wang, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16411 · Cited by 72
Gut, Microbiome, and Brain Regulatory Axis: Relevance to Neurodegenerative and Psychiatric Disorders
Stefano, G. B., Pilonis, N., Ptáček, R., Raboch, J., Vňuková, M., & Kream, R. M. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0589-2 · Cited by 74
D’Acunto, G., Nageye, F., Zhang, J., Masi, G., & Cortese, S. (2019) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2019.0015 · Cited by 71
Riggs, L. M., Aracava, Y., Zanos, P., Fischell, J., Albuquerque, E. X., Pereira, E. F. R., Thompson, S. M., & Gould, T. D. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-019-0443-3 · Cited by 66
Self-citationWeger, M., Alpern, D., Cherix, A., Ghosal, S., Grosse, J., Russeil, J., Rolf Gruetter, A., de Kloet, E. R., Deplancke, B., & Sandi, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-75326-9 · Cited by 71
Nrf2 regulates iron-dependent hippocampal synapses and functional connectivity damage in depression
Zeng, T., Li, J., Xie, L., Dong, Z., Chen, Q., Huang, S., Xie, S., Lai, Y., Li, J., Yan, W., et al. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02875-x · Cited by 74
Brancato, A., Bregman, D., Ahn, H. F., Pfau, M. L., Ménard, C., Cannizzaro, C., Russo, S. J., & Hodes, G. E. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.03.014 · Cited by 73
Shuto, T., Kuroiwa, M., Sotogaku, N., Kawahara, Y., Oh, Y., Jang, J.-H., Shin, C.-H., Ohnishi, Y. N., Hanada, Y., Miyakawa, T., et al. (2018) · Molecular Psychiatry · doi:10.1038/s41380-018-0316-x · Cited by 64
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics
Barygin, O. I., Nagaeva, E. I., Tikhonov, D. B., Belinskaya, D. A., Vanchakova, N. P., & Shestakova, N. N. (2017) · Brain Research · doi:10.1016/j.brainres.2017.01.028 · Cited by 68
Li, M., Li, Q., Sun, X., Luo, C., Li, Y., Wang, Y., Chen, J., Gong, C.-Z., Li, Y., Shi, L.-P., et al. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109682 · Cited by 65
Page, C. E., Epperson, C. N., Novick, A. M., Duffy, K. A., & Thompson, S. M. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02625-2 · Cited by 80
Self-citationWhy depression and pain often coexist and mutually reinforce: Role of the lateral habenula
Li, J., Li, Y., Zhang, B., Shen, X., & Zhao, H. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.08.010 · Cited by 63
Wang, W., Liu, L., Yang, X., Gao, H. T., Tang, Q., Yin, L.-Y., Yin, X., Hao, J., Geng, D., & Gao, C. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.01.057 · Cited by 62
Nuno‐Perez, A., Trusel, M., Lalive, A. L., Congiu, M., Gastaldo, D., Tchenio, A., Lecca, S., Soiza‐Reilly, M., Bagni, C., & Mameli, M. (2021) · Neuron · doi:10.1016/j.neuron.2021.01.008 · Cited by 58
Malvestio, R. B., de Medeiros, P. S., Negrini-Ferrari, S. E., Oliveira-Silva, M., Medeiros, A. C., Padovan, C. M., Luongo, L., Maione, S., Coimbra, N. C., & de Freitas, R. L. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.06.017 · Cited by 60
Xu, A., Cui, S., & Wang, J. (2015) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyv122 · Cited by 56
Hong, R., Luo, L., Wang, L., Hu, Z., Yin, Q., Li, M., Gu, B., Wang, B., Zhuang, T., Zhang, X., et al. (2023) · iMeta · doi:10.1002/imt2.116 · Cited by 57
Disruption of perineuronal nets increases the frequency of sharp wave ripple events
Sun, Z. Y., Bozzelli, P. L., Caccavano, A., Allen, M., Balmuth, J., Vicini, S., Wu, J., & Conant, K. E. (2017) · Hippocampus · doi:10.1002/hipo.22804 · Cited by 61
Bollinger, J. L., Dadosky, D. T., Flurer, J. K., Rainer, I. L., Woodburn, S. C., & Wohleb, E. S. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01519-7 · Cited by 55
Deficiency of tumor suppressor NDRG2 leads to attention deficit and hyperactive behavior
Li, Y., Yin, A., Sun, X., Zhang, M., Zhang, J., Wang, P., Xie, R., Li, W., Fan, Z., Zhu, Y., et al. (2017) · Journal of Clinical Investigation · doi:10.1172/jci94455 · Cited by 54
Jiang, H., Zhang, X., Lü, J., Meng, H., Sun, Y., Yang, X., Zhao, B., & Bao, T. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00102 · Cited by 54
Bilbao, A., Falfán-Melgoza, C., Leixner, S., Becker, R., Singaravelu, S. K., Sack, M., Sartorius, A., Spanagel, R., & Weber‐Fahr, W. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.04.020 · Cited by 53
Group II metabotropic glutamate receptor blockade promotes stress resilience in mice
Highland, J. N., Zanos, P., Georgiou, P., & Gould, T. D. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0380-1 · Cited by 53
Alaiyed, S., Bozzelli, P. L., Caccavano, A., Wu, J. Y., & Conant, K. E. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14671 · Cited by 52
Differential regulation of GluA1 expression by ketamine and memantine
Zhang, K., Yamaki, V. N., Wei, Z., Zheng, Y., & Cai, X. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.09.002 · Cited by 51
Self-citationMechanisms Underlying the Antidepressant Response of Acupuncture via PKA/CREB Signaling Pathway
Jiang, H., Zhang, X., Wang, Y., Zhang, H., Li, J., Yang, X., Zhao, B., Zhang, C., Yu, M., Xu, M., et al. (2017) · Neural Plasticity · doi:10.1155/2017/4135164 · Cited by 51
The dose makes the poison: From glutamate-mediated neurogenesis to neuronal atrophy and depression
Rubio-Casillas, A., & Fernández-Guasti, A. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2015-0066 · Cited by 49
Targeting metaplasticity mechanisms to promote sustained antidepressant actions
Brown, K. A., & Gould, T. D. (2024) · Molecular Psychiatry · doi:10.1038/s41380-023-02397-1 · Cited by 49
The potential of ketamine for posttraumatic stress disorder: a review of clinical evidence
Ragnhildstveit, A., Roscoe, J., Bass, L. C., Averill, C. L., Abdallah, C. G., & Averill, L. A. (2023) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253231154125 · Cited by 54
Bernstein, H., Meyer-Lotz, G., Dobrowolny, H., Bannier, J., Steiner, J. H., Walter, M., & Bogerts, B. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00273 · Cited by 48
Thompson, J. R., Nelson, E. D., Tippani, M., Ramnauth, A. D., Divecha, H. R., Miller, R. A., Eagles, N. J., Pattie, E. A., Kwon, S., Bach, S. V., et al. (2025) · Nature Neuroscience · doi:10.1038/s41593-025-02022-0 · Cited by 58
Zhang, B., Yang, X., Ye, L., Liu, R., Ye, B., Du, W., Shen, F., Li, Q., Guo, F., Liu, J., et al. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108382 · Cited by 47
Li, M., Sun, X., Wang, Z., & Li, Y. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02527-x · Cited by 45
Mokhtari, T. (2022) · Phytotherapy Research · doi:10.1002/ptr.7551 · Cited by 46
Fuxe, K., & Borroto-Escuela, D. O. (2015) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2015.1074175 · Cited by 43
WILLIAMS, E. S., Mazei‐Robison, M. S., & Robison, A. J. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a039198 · Cited by 44
Engaging homeostatic plasticity to treat depression
Workman, E. R., Niere, F., & Raab‐Graham, K. F. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.225 · Cited by 43
NLGN1 and NLGN2 in the prefrontal cortex: their role in memory consolidation and strengthening
Katzman, A. C., & Alberini, C. M. (2017) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.12.003 · Cited by 43
Qin, X., Shan, Q., Fang, H., Wang, Y., Chen, P., Xiong, Z., Swaab, D. F., & Zhou, J. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02371-7 · Cited by 42
Antidepressant mechanisms of ketamine: Focus on GABAergic inhibition
Lüscher, B., Feng, M., & Jefferson, S. J. (2020) · Advances in pharmacology · doi:10.1016/bs.apha.2020.03.002 · Cited by 41
Papp, M., Gruca, P., Lason-Tyburkiewicz, M., Litwa, E., Niemczyk, M., Tota-Glowczyk, K., & Willner, P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4651-4 · Cited by 40
Plasticity of synapses and reward circuit function in the genesis and treatment of depression
Thompson, S. M. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-022-01422-1 · Cited by 40
Self-citationFang, Q., Cai, H., Jiang, P., Zhao, H., Song, Y., Zhao, W., Yu, Y., & Zhu, J. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.01.051 · Cited by 38
Wu, Z., Cai, Z., Shi, H., Huang, X., Cai, M., Yuan, K., Huang, P., Shi, G., Yan, T., & Li, Z. (2022) · Aging · doi:10.18632/aging.204030 · Cited by 37
Huang, S., Zheng, C., Xie, G., Song, Z., Wang, P., Bai, Y., Chen, D., Zhang, Y., Lv, P., Liang, W., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0720-x · Cited by 36
Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking
He, J.-G., Zhou, H.-Y., Wang, F., & Chen, J.-G. (2023) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2022.02.007 · Cited by 36
Wang, Y., Jiang, H., Meng, H., Lü, J., Li, J., Zhang, X., Yang, X., Zhao, B., Sun, Y., & Bao, T. (2017) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2017.07.021 · Cited by 36
Blanco, I., & Conant, K. E. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14910 · Cited by 44
Repurposing of Drugs–The Ketamine Story
Das, J. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01193 · Cited by 41
Metadata
- Authors
- Thompson, S. M., Kallarackal, A. J., Kvarta, M. D., Van Dyke, A. M., LeGates, T. A., & Cai, X.
- Affiliations
- University of Maryland, Baltimore (US)
- Southern Illinois University Carbondale (US)
- Corresponding author
- Thompson, Scott M.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2015-05
- Volume
- 38
- Issue
- 5
- Pages
- 279-294
- ISSN
- 0166-2236 (ISSN-L)
- PMC
- PMC4417609
- OpenAlex
- W2088861514
- Cited by
- 265
- References
- 203
- Citations by year
- 2026: 5 · 2025: 17 · 2024: 23 · 2023: 34 · 2022: 23 · 2021: 33 · 2020: 29 · 2019: 28 · 2018: 20 · 2017: 22 · 2016: 17 · 2015: 14
- FWCI
- 3.05
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Neurosciences (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (2t32ns063391-21)
- National Institute of Mental Health (R01MH086828)
- National Institute of General Medical Sciences (T32GM008181, T32GM092237)
- National Institute of Neurological Disorders and Stroke (T32NS007375, T32-NS063391)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- depression, glutamatergic synapses, chronic stress, genetic susceptibility, prefrontal cortex, hippocampus, nucleus accumbens, antidepressant treatment, synaptic plasticity
- MeSH terms
- Animals, Antidepressive Agents, Brain, Depression, Humans, Synapses, Excitatory Postsynaptic Potentials
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
